CSL lifts profit
November 29, 2012
CSL has lifted its outlook for fiscal
2013, saying it expects net profit to
grow by around 20%, despite
competitive business conditions.
The prediction is an 8% jump on
2013 guidance outlined in August,
in which the company said it
expected profit to grow
approximately 12% during fiscal 2013.
“I am pleased to report an
improved company outlook for the
financial year, largely underpinned
by the performance of CSL
Behring,” said Dr Brian McNamee,
CSL’s Managing Director.
“A number of factors have
contributed including a higher level
of sales, a better sales mix and
improved efficiencies across the
supply chain.
“Also contributing to the better
outlook is higher than anticipated
royalty income from sales of
Gardasil,” he added.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Nov 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Nov 12
